Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00987298 · ClinicalTrials.gov registry record
Technical Validation of Lunar iDXA (GE Healthcare) Visceral Fat Tool
A clinical trial, sponsored by GE Healthcare.
- Completed
- Registry status
- 124
- Enrollment target
NCT00987298: Completed study, sponsored by GE Healthcare.
NCT00987298 is a clinical trial that has completed, run by GE Healthcare. The registered enrollment target is 124 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00987298 has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- 124 participants
- Enrollment target
Study Summary
The goal of this project is to compare visceral fat measurements derived from Lunar iDXA total body scans and from Computed Tomography (CT) scans of the abdominal region.
Interventions
- DEVICE Visceral fat mass measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2009-12 |
| Est. Completion | 2010-06 |
What the finished NCT00987298 record still lists
NCT00987298 is an observational study that tracks outcomes without assigning an intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Visceral fat mass measurement is the first listed.
NCT00987298 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00987298 about?
NCT00987298 is a clinical study titled "Technical Validation of Lunar iDXA (GE Healthcare) Visceral Fat Tool". The goal of this project is to compare visceral fat measurements derived from Lunar iDXA total body scans and from Computed Tomography (CT) scans of the abdominal region.
What is the current status of trial NCT00987298?
This trial is currently completed. The enrollment target is 124 participants. The study started on 2009-12. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00987298?
The interventions under investigation include: Visceral fat mass measurement (DEVICE).
Who is sponsoring clinical trial NCT00987298?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523014 · 124 participants · Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- NCT02670707 · 124 participants · Phase 3
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- NCT02830724 · 124 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- NCT04748809 · 124 participants · NA
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia